Acadia History
Top-level overview statement to set up the page. ipsum dolor sit amet, consectetur adipiscing elit. Nulla semper.
For over 25 years, Acadia has been trailblazing breakthroughs for people with neurological conditions.
The Acadia family continues to fulfill the promise of science to deliver vital solutions to people who need them most to help enable brighter moments to shine through for patients & their loved ones. We invite you to learn more about our history.
Lorem Ipsum
Acadia and Neuren Pharmaceuticals announce rare pediatric disease designation for trofinetide for the treatment of Rett syndrome*
Acadia Pharmaceuticals acquires CerSci Therapeutics, adds novel pain program to portfolio. Acadia and Neuren Pharmaceuticals announce rare pediatric disease designation for trofinetide for the treatment of Rett syndrome*
LAAAA Acadia Pharmaceuticals acquires CerSci Therapeutics, adds novel pain program to portfolio. Acadia and Neuren Pharmaceuticals announce rare pediatric disease designation for trofinetide for the treatment of Rett syndrome*
new event
description
new event caption
2018
lorem ipsum lorem ipsum lorem ipsum
lorem ipsum
2017
lorem ipsum
lorem ipsum
lorem ipsum
lorem ipsum
Lorem ipsum 2
asdADAASDVASVASDV
ASD VASD
ASD AS ASDF ASasdvasvasdvas
sf
1995
lorem ipsum lorem ipsum
1994
lorem ipsum
Lorem ipsum 3
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
slider 2